Imedex E-learning (audio)

Koen von Besien, MD, PhD: AML 60-80 years: Who should get an allo transplant?

Informações:

Sinopsis

Webcast: FLT3 Targets in R/R AML: Evaluating Emerging Clinical Data and Implications on Current Practice